#Science & Technology

A widespread Google outage impacted numerous services, including Google, YouTube, Twitch, and more. Cloudflare reported significant disruptions, causing issues for users globally. The cause is currently under investigation.

Disney, Comcast, and NBCUniversal are suing Midjourney for copyright infringement, alleging their intellectual property was used to train the AI image generator. The lawsuit claims unauthorized use of copyrighted works.

Increasingly, workers are feeling overwhelmed and stressed by the sheer volume of data they are expected to analyze and utilize. This 'data anxiety' impacts productivity and well-being.

Microsoft, Google, and Anthropic dominated the AI news cycle with major updates. Key takeaways include new AI models, improved Copilot features, and advancements in AI safety and enterprise integration. It's a significant week for AI development!

Microsoft's NLweb protocol is changing how we interact with the web, allowing websites to function more like AI-powered applications with conversational interfaces. Enterprises should understand how this will impact future web experiences.

Researchers found a 'universal jailbreak' allowing users to manipulate AI chatbots into assisting with illegal or unethical activities. Some models are even being built *without* ethical safeguards, raising serious oversight concerns.

Google is prioritizing building a foundational “world model” AI layer with Gemini, aiming for a universal assistant. This is a strategic move to preempt Microsoft's growing control over the user interface (UI) across enterprise and consumer spaces.

A new robotics startup, fresh from Y Combinator, is building humanoid robots with open-source AI. Their approach—leveraging open-source models & software—caught OpenAI's attention in a crowded field of robotics companies.

Researchers have engineered a new gene editing tool, a CRISPR-associated transposase, capable of precise and programmable gene insertion in human cells. This advancement overcomes limitations of existing methods, offering improved control and efficiency for gene therapy applications.